An award-winning doctor in the research of gastroenterology, Dr. Gibson brings years of experience studying how the gut microbiome develops in response to environmental cues like diet.
REDWOOD CITY, Calif., Aug. 2, 2018 /CNW/ -- The Biocodex Microbiota Foundation (BMF), an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the structure of microbiota, announced today that it has added Dr. Deanna Gibson to its Canadian scientific advisory board. The board plays an active role in encouraging research into microbiota and its interaction with various pathologies and oversees selection of young researchers in Canada who are awarded grants from the foundation.
"The Biocodex Microbiota Foundation fosters and advances research that is very evidence based," said Dr. Gibson. "That is central to how I think research should be conducted. Evidence comes first."
Dr. Gibson's early years set her up for disciplined study. She received her Bachelor of Science and doctorate degrees in microbiology and biochemistry from the University of Victoria in Canada, and after time spent immersed in molecular study, decided to expand into patient-focused work. She has completed post-doctorate work in gastroenterology with the department of pediatrics at the BC Women's Hospital & Health Centre in Vancouver, British Columbia.
"For many years, a lot of nutrition research was not done well. It was not properly controlled, not well thought out, and not executed well," said Gibson. "But what is in our gut affects this huge population of microbiomes, and patients want to know about diet. My research is very patient driven, and I also bring my scientific skills into the equation."
One major focus of Dr. Gibson's research has been the effect of dietary lipids on the gut microbiome and immunity. She is currently working on clinical studies of various diets with the goal of generating evidence to support dietary recommendations for patients with inflammatory bowel disease (IBD).
The Biocodex Microbiota Foundation's annual calls for projects is part of a multi-year research initiative to understand the interaction between microbiota and different pathologies. Dr. Gibson said she is particularly enthusiastic about the call for projects.
"I am looking forward to being involved in the grants. I am so excited to read the applications and see the creativity of these young researchers," said Dr. Gibson.
Biocodex, a global pharmaceutical company and maker of the probiotic Florastor®, has been a leading researcher and provider in the microbiota field for the last 60 years. As the company continues to evolve, more emphasis has been placed on advancing the understanding between human microbiota and various pathologies. Launched in February of 2017, the Biocodex Microbiota Foundation was created to inspire innovative scientists around the world and advance research of the human microbiota and gut flora.
For more information on the Biocodex Microbiota Foundation, visit http://www.biocodexmicrobiotafoundation.com/foundation.
About Biocodex Microbiota Foundation
The Biocodex Microbiota Foundation's mission is to support research into microbiota and its interaction with various pathologies. Research is supported through grants given to projects that investigate the implication of microbiota in human health. BMF supports both fundamental and applied research, and projects are selected annually by a committee of independent, international scientists.
The BMF's primary activity remains the awarding of annual grants to innovative scientific research projects that explore the structure and impact of microbiota. The BMF also runs and helps establish programs to improve our understanding of microbiota and disseminates this knowledge as widely as possible. Finally, the BMF can establish public projects involving microbiota which aim to help improve human health.
The Biocodex Microbiota Foundation (BMF) is a non-profit, general interest organization.
SOURCE Biocodex Microbiota Foundation